Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

Transgene's immunotherapy product gets Orphan Drug Designation from EC...
July 28, 2003

Valentis initiates Ph II trial of its Del-1 product in PAD.
July 28, 2003

Bill Andeson becomes CFO at Dow Pharma.
July 28, 2003

LAB International names Desmond Cave director, business development, E...
July 28, 2003

Vertex names Peter Mueller CSO and senior VP, drug discovoery.
July 28, 2003

Promotions at Genentech.
July 28, 2003

Dendreon and Corvas shareholders urged to vote for merger.
July 28, 2003

Baxter shifts Bioset production to Malta.
July 28, 2003

CAT promotes Richard Mason to VP business development.
July 28, 2003

SPECTRUM.
July 28, 2003

Stock Commentary - Europe.
July 28, 2003

Stock Commentary - Tokyo.
July 28, 2003

Stock Commentary - New York.
July 28, 2003

AstraZeneca raises full-year earnings guidance.
July 28, 2003

Safeways raises $2.5M for prostate cancer resarch.
July 28, 2003

Draxis completes pharma unit divestiture.
July 28, 2003

Antidepressants; staying the course for better results.
July 28, 2003

Antisoma R1549 trial results likely sooner.
July 28, 2003

PRIMABioMed sees positive Ph Ib results with cell-based therapy.
July 28, 2003

Positive results for Vecura's VRoo4 in ED.
July 28, 2003

AVANT's novel cholesterol management vaccine well-tolerated.
July 28, 2003

Rigel's R112 inhibits allergic chemical medicators in inflammation.
July 28, 2003

Medtronic initiates drug-eluting stent trial.
July 28, 2003

Galen Merger talks terminated.
July 28, 2003

Waksal leaves ImClone, new era for firm?
July 28, 2003

Tissue microarrays as tools for cancer researchers.
July 28, 2003

Amylin repays J&J loans from prior Symlin collaboration.
July 28, 2003

ILEX offer 5.5 million shares.
July 28, 2003

Meridian to make/ distribute Corixa Chagas' proteins.
July 28, 2003

Tokyo pharma stocks - week to July 21.
July 28, 2003

NPS Pharma settles claim against Forest.
July 28, 2003

TAC to supply ARVs to 2nd S African province.
July 28, 2003

USA to showcase S African AIDS plan?
July 28, 2003

S African disobedience threat over ARV study.
July 28, 2003

Zimbabwe "to offer ARVs by year-end".
July 28, 2003

New FDA initiative heightens US battle against counterfeit drugs.
July 28, 2003

UPDATE: Galen merger talks with Barr terminated as share price is driv...
July 28, 2003

Profits up at Merck & Co on branded sales but still lower than estimat...
July 28, 2003

Alteon's hypertension drug fails to achieve main goal in Phase IIb tri...
July 28, 2003

Arixtra prevents VTE in surgery patients.
July 28, 2003

Onyx seeks $71 million from stock offering.
July 28, 2003

Futura Medical joins UK's AIM listing.
July 28, 2003

Irish pharmacists slam drug shortages.
July 28, 2003

German reform to cost pharma 1B euros/year.
July 28, 2003

French 1st-half health spending soars.
July 28, 2003

UK NICE Rx guidance for heart failure.
July 28, 2003

Second-quarter losses narrow at Millennium.
July 28, 2003

Australia develops lactose process for pharma industry.
July 28, 2003

TransForm gains US govt contract to develop technology.
July 28, 2003

Roche posts sharp fall in 1st-half profit.
July 28, 2003

Sales up 14% at Sanofi-Synthelabo in 1st half.
July 28, 2003

Akzo pharma unit struggles in 2nd qtr.
July 28, 2003

Generics push S-P profits down 71%.
July 28, 2003

GSK 2nd-qtr earnings beat forecasts.
July 28, 2003

Strathmann Biotec and QIAGEN extend collaboration.
July 28, 2003

CuraGen's new predictive drug development assay.
July 28, 2003

SIGA and TransTech searching for SARS treatment.
July 28, 2003

Sanofi-Synthelabo and Celsis enter agreement.
July 28, 2003

Riken subscribes to Inpharmatica's Biopendium.
July 28, 2003

Degussa offers new service platform.
July 28, 2003

US House Leader slams "horrible" import bill.
July 28, 2003

US Senate panel views DTC drug ads.
July 28, 2003

Schizophrenia management dependent on treatment choice, says SOHO stud...
July 28, 2003

Novartis' Certican approved in Sweden.
July 28, 2003

Roche buys rights to Cardion's CRB-15.
July 28, 2003

Geffrey Henderson named president Lilly Canada; Gaetano Crupi moves to...
July 28, 2003

GlaxoSmithKline to revamp Imigran promotion in Japan.
July 28, 2003

Harry Schrickx moves to OncoMethylome Sciences as VP busines developme...
July 28, 2003

Martek to acquire FermPro assets.
July 28, 2003

Mitsubishi to sell OTC operations to Sato.
July 28, 2003

Abiogen and BTG sign licensing deal.
July 28, 2003

Prima Biomed's anticancer cell-based therapy shows promise.
July 28, 2003

Pivotal Phase III trials for Otsuka's OPC-6535 commence.
July 28, 2003

Correction: AstraZeneca's Atacand.
July 28, 2003

Diversa acquires antifungals from GSK.
July 28, 2003

Page 1|2|3|4|5